Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hirokuni Mizoguchi"'
Autor:
Hiroshi Karasawa, Hirokuni Mizoguchi, Bryan Choi, Chia-Ling Hsieh, Masaaki Miyano, Yuu Moriya, Sasikumar Muthusamy, Koji Takakura, Kunihiko Suzuki, Yoshie Tsurumaki, Takeshi Watanabe, Karen Wen, Tomohiro Yoneda, Ta-Tung Yuan, Masayuki Nomura
Publikováno v:
Regenerative Therapy, Vol 26, Iss , Pp 967-980 (2024)
The 6th Asia Partnership Conference of Regenerative Medicine (APACRM) was held in person with online on April 20, 2023, to promote the regulatory harmonization of regenerative medicine products throughout Asia. Recognizing domestic regulatory guideli
Externí odkaz:
https://doaj.org/article/4806501293ea499390e9c584ceec36b2
Autor:
Hirokuni Mizoguchi, Alex J. Zhang, Pawan Kumar Gupta, Masato Komuro, Wong Kum Cheun, Chuan Wen Chiu, Bryan Choi
Publikováno v:
Regenerative Therapy, Vol 26, Iss , Pp 334-345 (2024)
Gene therapies, which include viral-vector gene delivery, genome editing, and genetically modified cell therapy, are innovative treatments with the potential to address the underlying genetic causes of disorders and to provide life-changing value in
Externí odkaz:
https://doaj.org/article/f7aed783acb04594b6ef749f7555cb31
Autor:
Shingo Kano, Hirokuni Mizoguchi
Publikováno v:
Scientometrics. 120:361-374
There are many rare diseases and biomedical research efforts for treatment of each disease have been ongoing. However, few reports are available to analyze overall trends for how research and development have been performed for rare diseases generall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59bb049dea7f24b10a3bb42eb66450e6
https://doi.org/10.1007/s11192-019-03129-5
https://doi.org/10.1007/s11192-019-03129-5
Publikováno v:
Drug discovery today. 21(10)
Orphan drug legislation has contributed enormously to promote drug development for rare diseases but further effective and sustainable approaches are required. This study focused on the difference of rare disease prevalence between Japan and Europe,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755227e7bc1c941654dbd462745f08f1
https://pubmed.ncbi.nlm.nih.gov/27371505
https://pubmed.ncbi.nlm.nih.gov/27371505
Publikováno v:
JOURNAL OF THE ILLUMINATING ENGINEERING INSTITUTE OF JAPAN. 79:249-249
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2e1897a8c36cda5d8539dd328a59bad
https://doi.org/10.2150/jieij1980.79.appendix_249
https://doi.org/10.2150/jieij1980.79.appendix_249
Publikováno v:
Gene Therapy Weekly; 7/19/2024, p46-46, 1p
Publikováno v:
Animal Science Journal. Dec2017, Vol. 88 Issue 12, p2107-2109. 3p.
Autor:
Mizoguchi, Hirokuni, Kano, Shingo
Publikováno v:
Scientometrics; Aug2019, Vol. 120 Issue 2, p361-374, 14p
Autor:
Mizoguchi H; Astellas Pharma Inc., Regulatory Affairs, 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan., Zhang AJ; Help Therapeutics Co. Ltd., 568 Longmian Avenue, Jiangning District, Nanjing, PR China., Gupta PK; Stempeutics Research Pvt. Ltd., Medical & Regulatory Affairs, Manipal Hospitals Whitefield, Bangalore, 560037, India., Komuro M; Sanofi K.K., Regulatory Affairs, Tokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, 163-1488, Japan., Cheun WK; Novartis Asia Pacific Pharmaceuticals Pte Ltd., Regulatory & Development Policy, Regulatory Affairs, Singapore., Chiu CW; TFBS Bioscience Inc., 3F., No.103, Ln. 169, Kangning St., Xizhi Dist., New Taipei City, Taiwan., Choi B; Inha University College of Medicine, Incheon, South Korea.
Publikováno v:
Regenerative therapy [Regen Ther] 2024 Jun 27; Vol. 26, pp. 334-345. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).